Target intelligence / Profile preview

Non-SATB2 mRNAs with seed-region complementarity

Molecular classification
mRNA, Nucleic acid
01

Overview

Non-SATB2 mRNAs with seed-region complementarity refers to a heterogeneous group of messenger RNA (mRNA) molecules that contain sequences matching the seed region of microRNAs (miRNAs) that also target the Special AT-rich sequence-binding protein 2 (SATB2). SATB2 is a critical transcription factor involved in craniofacial patterning, osteoblast differentiation, and neuronal development, and its dysregulation is linked to Glass syndrome and various cancers (UniProt Q9UPW6). Because miRNA-target recognition is primarily driven by a 6-8 nucleotide seed sequence, any mRNA possessing a complementary site can be suppressed by the same miRNA (Bartel, Cell, 2009). In the context of miRNA-based research or therapeutics aimed at SATB2, these non-SATB2 transcripts represent potential off-targets or co-regulated genes. Unintended silencing of these mRNAs can lead to complex phenotypic outcomes, off-target toxicity, or the masking of specific therapeutic effects (PubMed: 21933825). Consequently, identifying and monitoring these molecules is essential for evaluating the specificity and safety of RNA interference (RNAi) or miRNA-modulating strategies.

Other names
Seed-matched non-SATB2 transcriptsmiRNA off-targets (non-SATB2)Co-regulated seed-complementary mRNAs
02

Mechanism of action

MicroRNA-mediated gene silencing via the RNA-induced silencing complex (RISC), which involves seed-region pairing to the 3' untranslated region (UTR) of target mRNAs, leading to translational repression or transcript degradation (Bartel, Cell, 2009).

03

Biological functions

Post-transcriptional regulationGene silencingmRNA degradationTranslational inhibition
04

Disease associations

CancerNeurodevelopmental disordersCleft palateGlass syndrome
05

Safety considerations

Off-target gene silencingUnintended phenotypic changesSystemic toxicity from non-specific miRNA bindingCompetitive binding (sponge effect)

Beyond the preview

Go deeper on Non-SATB2 mRNAs with seed-region complementarity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-SATB2 mRNAs with seed-region complementarity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call